Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)

We compared the efficacy and safety of low-molecular-weight heparins (LMWHs) in patients with cancer who are at low risk of venous thromboembolism (VTE). Patients were treated by medical oncologists in Turkey at 15 sites, where they were enrolled and followed up for a period of 12 months. Due to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozaslan, Ersin, Ozkan, Metin, Cicin, Irfan, Benekli, Mustafa, Kocer, Murat, Uysal, Mukremin, Oksuzoglu, Berna, Isikdogan, Abdurrahman, Cubukcu, Erdem, Elkiran, Emin T., Dane, Faysal, Aliustaoglu, Mehmet, Sevinc, Alper, Karaoglu, Aziz, Ulas, Arife, Gokoz-Dogu, Gamze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714721/
https://www.ncbi.nlm.nih.gov/pubmed/29455568
http://dx.doi.org/10.1177/1076029617753538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714721/
https://www.ncbi.nlm.nih.gov/pubmed/29455568
http://dx.doi.org/10.1177/1076029617753538

Ejemplares similares